MATERIAL SAFETY DATA SHEET (Intermediate) Product:
1,1'- METHYLENEBIS (ISOCYANATOBENZENE) 26447-40-5
This product contains the following toxic chemical or chemicals subject to the reporting requirements of Section 313 of Title III of the Emergency Planning and Community Right-To-Know Act of 1986 and 40 CFR Part 372: BENZOYL CHLORIDE 2. PHYSICAL DATA BOILING POINT:
N/D - Not Determined N/A - Not Applicable
3. FIRE AND EXPLOSION HAZARD DATA FLASH POINT:
Wear full protective clothing, including helmet, self-contained, positive
pressure or pressure demand breathing apparatus, bunker coat and
pants, bands around arms, waist and legs, face mask, and protective
INCOMPATIBILITY-MATERIALS/CONDITIONS TO AVOID:
HAZARDOUS DECOMPOSITION PRODUCTS: Carbon Monoxide and Carbon
5. ENVIRONMENTAL INFORMATION SPILL RESPONSE:
Contain spill. Cover with absorbent material. Collect spilled material.
EPCRA HAZARD CASS: FIRE HAZARD: No PRESSURE: NO REACTIVITY: No ACUTE: YES CHRONIC: No 6. SUGGESTED FIRST AID EYE CONTACT:
Immediately flush eyes with large amounts of water for at least 15
minutes. Get immediate medical attention.
Flush skin with large amounts of water. If irritation persists, get medical
If signs/symptoms occur, remove person to fresh air. If signs/symptoms
Drink two glasses o water. Call a physician.
7. PRECAUTIONARY INFORMATION EYE PROTECTION:
Avoid prolonged or repeated skin contact. Wear appropriate gloves
Avoid breathing of vapors created during the cure cycle.
Wash hands after handling and before eating. Do not ingest.
Store away from heat. Store out of direct sunlight. Keep container dry.
For best performance, store between 40-80 F.
*SKIN NOTATION: Listed substances indicated with 'Y' under SKIN refer to the potential contribution to the overall exposure by the cutaneous route including mucous membrane and eye, either by airborne or, more particularly, by direct contact with the substance. Vehicles can alter skin absorption.
SOURCE OF EXPOSURE LIMIT DATA: - ACGIH: American Conference of Governmental Industrial Hygienists - OSHA: Occupational Safety and Health Administration - CMRG: Chemical Manufacturer Recommended Exposure Guidelines - NONE: None Established - AIHA: American Industrial Hygiene Assoc. Workplace Environmental
Mild Eye Irritation: signs/symptoms can include redness, swelling, pain,
Mild Skin Irritation (after prolonged or repeated contact):
signs/symptoms can include redness, swelling, and itching.
WHILE THE FOLLOWING EFFECTS ARE ASSOCIATED WITH ONE OR MORE OF
THE INDIVIDUAL INGREDIENTS IN THIS PRODUCT AND ARE REQUIRED TO BE
INCLUDED ON THE MSDS BY THE U.S. OSHA HAZARD COMMUNICATION
STANDARD, THEY ARE NOT EXPECTED DURING FORESEEABLE USE OF THIS
Allergic skin Reaction: signs/symptoms can include redness, swelling,
Those people with bronchial problems or with isocyanate sensitivity may
respond to low isocyanate concentrations, although no known
occurrences have occurred with this product.
WHILE THE FOLLOWING EFFECTS ARE ASSOCIATED WITH ONE OR MORE OF
THE INDIVIDUAL INGREDIENTS IN THIS PRODUCT AND ARE REQUIRED TO BE
INCLUDED ON THE MSDS BY THE U.S. OSHA HAZARD COMMUNICATION
STANDARD, THEY ARE NOT EXPECTED EFFECTS DURING FORESEEABLE USE
Prolonged or repeated exposure may cause:
Allergic Respiratory Reaction: signs/symptoms can include difficulty
breathing, wheezing, tightness of chest, and respiratory failure.
Irritation (upper respiratory): signs/symptoms can include soreness of the
Ingestion is not a likely route of exposure to this product.
WHILE THE FOLLOWING EFFECTS ARE ASSOCIATED WITH ONE OR MORE OF
THE INDIVIDUAL INGREDIENTS IN THIS PRODUCT AND ARE REQUIRED TO BE
INCLUDED ON THE MSDS BY THE U.S. OSHA HAZARD COMMUNICATION
STANDARD, THEY ARE NOT EXPECTED EFFECTS DURING FORESEEABLE USE
Irritation of Gastrointestinal Tissues: signs/symptoms can include pain,
vomiting, abdominal tenderness, nauses, blood in vomitue, and blood in
The information on this Data sheet represents our current data and best opinion as to the proper use and handling of this product under normal conditions. Any use of the product which is not in conformance with this Data Sheet or which involves using the product in combination with any other product or any other process is the responsibility of the user.
Measuring the quality of life of cancer patients with The Rotterdam Symptom Checklist ()Northern Centre for Healthcare Research (NCH) University of Groningen, The Netherlands Department of Medical Psychology, Academic Medical Center Amsterdam; Department of Medical Decision Making, University Hospital, Leiden, The Netherlands Medical Biometrics, University Hospital Freiburg,
Patient Group Direction For The Supply Of Doxycycline For The Prophylaxis Of Malaria By Nurses Working In Occupational Health And Pharmacists Working Within NHS Grampian Co-ordinators: Consultation Group : Approver: Directorate Signature: Signature: Identifier: Review Date: Date Approved: A Patient Group Direction is a specific written ins